Rare antibodies from combinatorial libraries suggests an S.O.S. component of the human immunological repertoire

Molecular BioSystems

Volumn 7, Issue 4, 2011, Pages 1004-1012

  Lerner, Richard A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; VACCINE;

ANIMAL; CHEMISTRY; DNA REPAIR; GENETICS; HUMAN; IMMUNOLOGY; INFECTION; NEOPLASM; ORTHOMYXOVIRUS; REVIEW;

ANIMALS; ANTIBODIES; HUMANS; INFECTION; NEOPLASMS; ORTHOMYXOVIRIDAE; SOS RESPONSE (GENETICS); VACCINES;

ORTHOMYXOVIRIDAE;

EID: 79952640176     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c0mb00310g     Document Type: Review

References (52)

1. A. K. Kashyap, et al., Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies, Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 5986-5991.
2. M. Throsby, et al., Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM memory B cells, PLoS One, 2008, 3, e3942.
3. I. Wilson, et al., Antibody recognition of a highly conserved influenza virus epitope, Science, 2009, 324, 246-251.
4. W. A. Marasco, et al., Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses, Nat. Struct. Mol. Biol., 2009, 16, 265-273.
5. W. D. Huse, et al., Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda, Science, 1989, 246, 1275-1281.
6. R. Orlandi, D. H. Güssow, P. T. Jones and G. Winter, Cloning immunoglobulin variable domains for expression by the polymerase chain reaction, Proc. Natl. Acad. Sci. U. S. A., 1989, 86, 3833-3837.
7. L. Sastry, et al., Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: Construction of a heavy chain variable region-specific cDNA library, Proc. Natl. Acad. Sci. U. S. A., 1989, 86, 5728-5732.
8. J. McCafferty, A. D. Griffiths, G. Winter and D. J. Chiswell, Phage antibodies: filamentous phage displaying antibody variable domains, Nature, 1990, 348, 552-554.
9. C. F. Barbas, A. S. Kang, R. A. Lerner and S. J. Benkovic, Assembly of combinatorial antibody libraries on phage surfaces: the gene III site, Proc. Natl. Acad. Sci. U. S. A., 1991, 88, 7978-7982.
10. R. A. Lerner, Manufacturing immunity to disease in a test tube: the magic bullet realized, Angew. Chem., Int. Ed., 2006, 45, 8106-8125.
11. R. A. Lerner, C. F. Barbas, A. S. Kang and B. R. Burton, On the use of combinatorial antibody libraries to clone the ''fossil record'' of an individual's immune response, Proc. Natl. Acad. Sci. U. S. A., 1991, 88, 9705-9706.
12. R. Dwek, Antibodies and antigens: it's all about the numbers game, Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 2087-2088.
13. T. Ota, T. Sitnikova and M. Nei, Evolution of vertebrate immunoglobulin variable gene segments, Curr. Top. Microbiol. Immunol., 2000, 248, 221-245.
14. E. E. Max, in Fundamental Immunology, ed. W. E. Paul, Lippincott Williams & Wilkins, 2008, pp. 192-236.
15. L. C. James, P. Roversi and D. S. Tawfik, Antibody multispecificity mediated by conformational diversity, Science, 2003, 299, 1362-1367.
16. I. A. Wilson and R. L. Stanfield, Antibody-antigen interactions: new structures and new conformational changes, Curr. Opin. Struct. Biol., 1994, 4, 857-867.
17. F. E. Romesberg, B. Spiller, P. G. Schultz and R. C. Stevens, Immunological origins of binding and catalysis in a Diels-Alderase antibody, Science, 1998, 279, 1929-1933.
18. C. Janeway, The immune system evolved to discriminate infections nonself from noninfectious self, Immunol. Today, 1992, 13, 11-16.
19. M. Cohn and R. E. Langman, The protection: the unit of humoral immunity selected by evolution, Immunol. Rev., 1990, 115, 7-147.
20. E. Hsu, Canonical VH CDR1 nucleotide sequences are conserved in all jawed vertebrates, Int. Immunol., 1996, 8, 847-854.
21. B. Chang and P. Casali, The CDR1 sequence of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement, Immunol. Today, 1994, 15(8), 367-373.
22. I. M. Tomlinson, et al., The imprint of somatic hypermutation on the repertoire of human germline V genes, J. Mol. Biol., 1996, 256, 813-817.
23. C. C. Huang, et al., Structural basis of tyrosine sulfation and Vh-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120, Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 2706-2711.
24. M. A. Luftig, et al., Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directedantibody, Nat. Struct. Mol. Biol., 2006, 13, 740-747.
25. C. H. Chan, K. G. Hadlock, S. K. Foung and S. Levy, Vh1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen, Blood, 2001, 97, 1023-1026.
26. M. Zemlin, et al., Regulation of repertoire development through genetic control of DH reading frame preference, J. Immunol., 2008, 181, 8416-8424.
27. M. Zemlin, et al., Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures, J. Mol. Biol., 2003, 334, 733-749.
28. H. W. Schroeder, J. L. Hillson and R. M. Perlmutter, Early restriction of the human antibody repertoire, Science, 1987, 238, 791-793.
29. J. J. Kenny, et al., I. mice expressing the xid immune defect provide normal help to T15 B cell precursors, J. Immunol., 1982, 129, 1534-1538.
30. U. Kalinke, et al., The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus, Immunity, 1996, 5, 639-652.
31. U. Kalinke, A. Oxenius, C. Lopez-Macias, R. M. Zinkernagel and H. Hengartner, Virus neutralization by germ-line vs. hypermutated antibodies, Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 10126-10131.
32. S. H. Clarke, et al., V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin, J. Immunol., 1990, 144, 2795-2801.
33. N. Baumgarth, J. W. Tung and L. Herzenberg, Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion, Semin. Immunopathol., 2005, 26, 347-362.
34. F. M. Martin, A. M. Oliver and J. F. Kearney, Marginal zone and B1 B cells unite in the early response against T-independent bloodborne particulate antigens, Immunity, 2001, 14, 617-629.
35. T. A. Johnson, L. Z. Rassenti and T. J. Kipps, IG VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features, J. Immunol., 1997, 158, 235-246.
36. T. J. Kipps, et al., Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia, Proc. Natl. Acad. Sci. U. S. A., 1989, 86, 5913-5917.
37. A. C. Wotherspoon, et al., Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori, Lancet, 1993, 342, 575.
38. T. Wündisch, et al., Etiology and therapy of Helicobacter pylori-associated gastric lymphomas, Ann. Hematol., 2003, 82, 535.
39. I. R. Mackay and N. R. Rose, Autoimmunity and lymphoma: tribulations of B cells, Nat. Immunol., 2001, 2, 793.
40. M. Libra, et al., Extrahepatic Disorders of HCV infection: a distinct entity of B-cell neoplasia?, Int. J. Oncol., 2010, 36, 1331.
41. S. Salomonsson, et al., Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome, Arthritis Rheum., 2003, 48, 3187.
42. F. Barone, et al., Association of CSCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome, Arthritis Rheum., 2005, 52, 1773-1784.
43. T. Marinkovic, et al., Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid, J. Clin. Invest., 2006, 116, 2622.
44. M. P. Armengol, Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expressing in chemokine-containing active intrathyroidal germinal centers, Am. J. Pathol., 2001, 159, 861.
45. F. Bertoni and E. Zucca, Delving deeper into MALT lymphoma biology, J. Clin. Invest., 2006, 116, 22.
46. A. Zullo, et al., Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis, Am. J. Gastroenterol., 2009, 104, 1932.
47. D. Burton, Antibodies, viruses and vaccines, Nature, 2002, 2, 706-713.
48. P. W. H. I. Parren, et al., Erratum to ̈Relevance of the antibody response against human immunodeficiencyvirus type 1 envelope to vaccine design", Immunol. Lett., 1997, 58, 125-132.
49. M. Law, P. P. Sanna and D. Burton, in Microbial Subversion of Immunity: Current Topics, ed. P. J. Lachmann, M. B. A. Oldstone, Caister Academic Press, 2006, pp.177-210.
50. M. Farhangi and E. F. Osserman, Myeloma with xanthoderma due to an IgG lambda monoclonal anti-flavin antibody, N. Engl. J. Med., 1976, 294, 177-183.
51. X. Zhu, P. Wentworth, R. A. Kyle, R. A. Lerner and I. A. Wilson, Cofactor-containing antibodies: crystal structure of the original yellow antibody, Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 3581-3585.
52. A. R. Gocke, D. G. Udugamasooriya, C. T. Archer, J. Lee and T. Kodadek, Synthetic antagonists of autoimmune T cell proliferation, Proc. Natl. Acad. Sci. U. S. A., 2009.